The expression of PD-L1 protein as a prognostic factor in lung squamous cell carcinoma
2016 · Lung Cancer · 72 citations
https://doi.org/10.1016/j.lungcan.2016.12.006
S
Shinkichi Takamori
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
245
Papers
3.3K
Citations
33
h-index
79
i10-index
Shinkichi Takamori is an academic researcher from Kyushu University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Diagnosis and Treatment. The author has an h-index of 33, co-authored 209 publications.
ORCID: 0000-0001-8175-6798Papers by this author
worksPrognostic Impact of Programmed Death-Ligand 2 Expression in Primary Lung Adenocarcinoma Patients
2019 · Annals of Surgical Oncology · 36 citations
https://doi.org/10.1245/s10434-019-07231-z
A Clinicopathological and Prognostic Analysis of PD-L2 Expression in Surgically Resected Primary Lung Squamous Cell Carcinoma
2019 · Annals of Surgical Oncology · 35 citations
https://doi.org/10.1245/s10434-019-07257-3
A propensity score-matched analysis of the impact of statin therapy on the outcomes of patients with non-small-cell lung cancer receiving anti-PD-1 monotherapy: a multicenter retrospective study
2022 · BMC Cancer · 30 citations
https://doi.org/10.1186/s12885-022-09385-8
Association between sex and outcomes in patients with non-small-cell lung cancer receiving combination chemoimmunotherapy as a first-line therapy: a systematic review and meta-analysis of randomized clinical trials
2022 · European journal of medical research · 13 citations
https://doi.org/10.1186/s40001-022-00789-7
Modulation of host glutamine anabolism enhances the sensitivity of small cell lung cancer to chemotherapy
2023 · Cell Reports · 12 citations
https://doi.org/10.1016/j.celrep.2023.112899
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat